Emotional and behavioural functioning in children with tyrosinaemia type 1. [PDF]
Pohorecka M +8 more
europepmc +1 more source
The Distinct Conformational Landscapes of 4S-Substituted Prolines That Promote an endo Ring Pucker. [PDF]
Costantini NV +5 more
europepmc +1 more source
Treatment adherence in tyrosinemia type 1 patients. [PDF]
González-Lamuño D +4 more
europepmc +1 more source
Patient-reported outcomes and functional assessments of patients with Alkaptonuria in a 3-year Nitisinone treatment trial. [PDF]
Spears KR +10 more
europepmc +1 more source
RICH1 is a novel key suppressor of isoproterenol‑ or angiotensin II‑induced cardiomyocyte hypertrophy. [PDF]
Wang S, Wang X, Ling L, Li C, Ren Z.
europepmc +1 more source
A Lithuanian Case of Tyrosinemia Type 1 with a Literature Review: A Rare Cause of Acute Liver Failure in Childhood. [PDF]
Rokaitė R +4 more
europepmc +1 more source
Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines. [PDF]
Kuypers AM +5 more
europepmc +1 more source
Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German-speaking countries. [PDF]
Das AM +18 more
europepmc +1 more source
Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria. [PDF]
Ranganath LR +11 more
europepmc +1 more source

